Navigation Links
Taking a Hard-Line Approach to Cardiovascular Risks in the Diabetes Patient
Date:5/18/2009

HOUSTON, May 18 /PRNewswire-USNewswire/ -- When treating the diabetes patient, doctors discussed how a "one size fits all" approach to testing is not enough to reveal an individual's risk for cardiovascular disease Saturday at the American Association of Clinical Endocrinologists (AACE) 18th Annual Meeting & Clinical Congress.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

"We need to be more aggressive in treating our patients," Howard S. Weintraub, MD, a cardiologist and Clinical Associate Professor of Medicine at NYU Medical School, said. "This requires individualized testing and early intervention."

Weintraub suggested that while gathering a patient's blood sugar data is important, assessing their results on an individual basis is crucial. Doing so may help to proactively identify the "constellation of issues" present in many patients.

This means placing more emphasis on the "diabetic state." By assessing factors like high blood pressure, bad cholesterol (LDL), blood sugar, triglycerides and weight, doctors can better predict the multiple cardiovascular risks likely to prey upon a patient.

"It's the physician's job to interpret all the risk factors and see the big picture," Weintraub said. "And appropriate action should be taken before it's too late."

For more information about preventive health measures and diabetes, download the American College of Endocrinology's (ACE) "Power of Prevention(R)" magazine here. The magazine features medical information on type 1 and type 2 diabetes, diabetes complications, and tips on how diabetes patients can best prepare for disaster.

ACE also issued a comprehensive treatment regimen for patients with prediabetes; a condition affecting more than 56 million Americans, which leaves them at risk for developing type 2 diabetes and cardiovascular complications. To download these recommendations click here.

A short, one-page bio and high resolution photo of Howard S. Weintraub, MD, is available here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Huge Drop in Preterm Birth-Risk Among Women Taking Folic Acid One Year Before Conception
2. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
3. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
4. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
5. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
6. Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth
7. Study Demonstrates Mindful Approach to Aging
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
10. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
11. Mosquito Season Approaching: American Heartworm Society Reminds Pet Owners of Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):